Literature DB >> 3701065

A monosaccharide precursor of Escherichia coli lipid A has the ability to induce tumor-cytotoxic factor production by a murine macrophage-like cell line, J774.1.

F Amano, M Nishijima, Y Akamatsu.   

Abstract

A monosaccharide precursor of Escherichia coli lipid A, designated lipid X, which is a diacylglucosamine 1-phosphate with beta-hydroxymyristoyl groups at positions 2 and 3, was shown to have the ability to induce the production of tumor necrosis factor (TNF)-like tumor-cytotoxic factor by a murine macrophage-like cell line, J774.1. This cytotoxic factor was released from J774.1 cells grown in the presence of lipid X and related compounds, and it was assayed as to its lytic activity against [3H]thymidine-labeled L929 cells. Dose-response studies revealed that lipid X induced the production of smaller amounts of the tumor-cytotoxic factor than LPS at low concentrations, but it induced that of considerable amounts at and over 1 microgram/ml. Elimination of 1-phosphate or 3-O-beta-hydroxymyristoyl group from lipid X completely prevented the induction of producing this factor by the macrophages. Therefore, it is suggested that both 1-phosphate and 3-O-beta-hydroxymyristoyl groups are essential for the biologic activity of lipid X, as to the induction of the tumor-cytotoxic factor production in the macrophages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  A lipopolysaccharide (LPS)-resistant mutant isolated from a macrophagelike cell line, J774.1, exhibits an altered activated-macrophage phenotype in response to LPS.

Authors:  F Amano; Y Akamatsu
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.

Authors:  H Saido-Sakanaka; J Ishibashi; A Sagisaka; E Momotani; M Yamakawa
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.

Authors:  G A Rook; J Taverne; C Leveton; J Steele
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion.

Authors:  A Mittelman; C Puccio; E Gafney; N Coombe; B Singh; D Wood; P Nadler; T Ahmed; Z Arlin
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.